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Abstract: Chemical investigation of the Mediterranean ascidian Ciona edwardsii has been 
performed,  leading  to  the  isolation  of  two  halogenated  compounds:  a  new  tyrosine-
iodinated derivative iodocionin (1) and the relevant brominated analogue (2), previously 
isolated from a Caribbean sponge. The structure of the new compound 1 has been assigned 
on the basis of spectroscopic analysis. Both compounds were tested for cytotoxicity in 
vitro against two different cancer cell lines, L5178Y (mouse lymphoma) and PC-12 (rat 
pheochromocytoma). Iodocionin was shown to possess significant and selective activity 
against lymphoma cells with an IC50 of 7.75 μg/mL. 
Keywords:  natural  products;  iodinated  metabolites;  cytotoxic  activity;  structure 
elucidation 
 
1. Introduction 
The  sea  is  a  large  source  of  biogenic  organohalogens,  which  are  biosynthesized  by  seaweeds, 
sponges,  corals,  tunicates,  bacteria,  and  other  marine  life  [1].  Halogenated  tyramine-derivatives 
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frequently occur in marine organisms and are known to play basic functions related to the survival of 
the living creatures producing them [2]. Bromine is by far the halogen most frequently found in these 
metabolites;  for  example,  bromotyrosine  derivatives  are  constantly  detected  among  the  secondary 
metabolites of the Demospongiae; thus, they have been used for taxonomic purposes [3–5]. On the 
contrary, iodinated metabolites, biosynthetically related to tyrosine, are much less widespread in the 
marine environment, since they have been isolated just in a few algae, microorganisms and marine 
invertebrates  [6,7].  We  wish  to  report  here  the  isolation  from  a  phlebobranchiate  ascidian,  Ciona 
edwardsii (species similar but distinct from C. intestinalis) of a new tyrosine-iodinated derivative, 
named iodocionin (1) together with the relevant brominated analogue 2, previously isolated from the 
Caribbean sponge Verongula gigantea [8]. Both compounds 1 and 2 were tested for their cytotoxic 
activity in vitro against two different cancer cell lines, L5178Y (mouse lymphoma) and PC-12 (rat 
pheochromocytoma). Iodocionin (1) was shown to possess a significant and selective activity against 
lymphoma cells. 
Figure 1. Structures of compounds 1 and 2. 
 
 
 
 
 
 
 
2. Results and Discussion  
2.1. Isolation and structure elucidation  
Specimens  of  C.  edwardsii  collected  in  the  bay  of  Naples  were  exhaustively  extracted  with 
methanol and, subsequently, with chloroform. The combined extracts were concentrated in vacuo; the 
resulting residue was partitioned between water and ethyl acetate and the polar layer was re-extracted 
with butanol. The butanol soluble material was initially subjected to chromatography over reverse 
phase silica gel column eluting with a solvent gradient from H2O/MeOH (9:1) to MeOH 100%. The 
MeOH/H2O 1:1 fraction was further separated by HPLC on a C18 reverse phase column (eluent: 
MeOH/aqueous  TFA  0.1%  7:3),  yielding  iodocionin  (1)  and  compound  2  in  the  pure  state.  The 
structure of the latter compound was deduced by comparison of its spectroscopic properties with those 
reported in literature [8]. 
The ESI mass spectrum of iodocionin (1) displayed a sole ion peak at m/z 306, corresponding to 
[M]
+. The molecular formula of 1 was established [HRFAB-MS (positive ions mode) analysis on the 
peak at m/z 306.0362 (calculated value: 306.0349)] as C11H17INO differing from that of 2 only in 
having a different halogen atom.  
1H and 
13C-NMR features of compound 1 were nearly identical to those of 2, with regard to the 
number and shape of the signals. However, differences were observed in the chemical shift values of 
1'
2'
3'
4'
5'
6' 2
1
R
HO
N
1 R = I
2 R = BrMar. Drugs 2010, 8                       
 
 
287 
the signals present in the downfield region of the spectra (see Table 1). Significantly different were the 
chemical shift values of two aromatic carbons [δ 140.5 in 1 vs. δ 134.6 in 2 (C-2’) and δ 84.7 in 1 vs.  
δ 111.2 in 2 (C-3’)] and of one of the aromatic protons [δ 7.68 vs. δ 7.49 (H-2’)]. These evidences 
suggested the presence in 1 of a 1,2,4-trisubstituted benzene ring like in 2 having, as substituents, an 
hydroxyl, a iodine atom and the -CH2CH2
+N(CH3)3 group. 
Table 1. NMR data (CD3OD) of 1 and 2. 
  1  2 
Pos.  H (mult., J in Hz)  C  H (mult., J in Hz)  C 
1’  -  129.2  -  129.2 
2’  7.68 (d, 2.1)  140.5  7.49 (d, 1.5)  134.6 
3’  -  84.7  -  111.2 
4’  -  157.3  -  154.9 
5’  6.81 (d, 8.3)  115.7  6.90 (d, 8.1)  117.7 
6’  7.14 (dd, 8.3, 2.1)  130.9  7.15 (dd, 8.1, 1.5)  130.3 
1  3.50 (m)  68.2  3.53 (m)  68.5 
2  3.01 (m)  28.6  3.05 (m)  29.1 
N(CH3)3  3.19 (s)  53.4  3.22 (s)  53.7 
 
In order to univocally assign the structure of 1, remained to establish the relative positions of the 
three substituents [-OH, -I, and -CH2CH2
+N(CH3)3]. It was deduced by analysis of HMBC data, as well 
as trough a quantitative estimation of heteronuclear coupling constants. 
The  methylene  protons  at  δ  3.01  (2H-2)  showed  key  HMBC  correlations  with  the  aromatic 
unprotonated carbon at δ 129.2 (C-1’), as well as with the two methine carbons at δ 130.9 (C-6’) and 
140.5 (C-2’), indicating  the location  of  -CH2-CH2-
+N(CH3)3 group at C-1’. Since H-6’ was ortho 
coupled  to  H-5’,  the  iodine  atom  and  the  hydroxyl  group  could  be  attached  at  C-3’  and  C-4’, 
respectively, or vice versa. The upfield chemical shift value of H-5’ (δ 6.81) was consistent with its 
location ortho to the phenolic group, suggesting for iodocionin the substituents location depicted in 
Figure 1. However, definitive information on the relative position of the three substituents has been 
obtained from the quantitative evaluation of 
nJ(C,H) coupling constants (Table 2) obtained through 
inspection of phase-sensitive HMBC data. The above evaluation could be easily accomplished since 
the carbons linked to the OH (δ 157.3) and I (δ 84.7), resonating at very different chemical shifts, were 
unambiguously  identified. In detail, H-2’ (δ 7.68) showed typical 
3JC-H large couplings with C-4’  
(δ 157.3) and C-6’ (δ 130.9), while a small coupling was found with C-3’ (δ 84.7) [9]. Accordingly,  
H-5’ (δ 6.81) showed large 
3JC-H coupling constants with C-1’ (δ 129.2) and C-3’, and small coupling 
constants with C-2’ (δ 140.5) and C-4’. Furthermore, H-6’ (δ 7.14) exhibited large coupling constants 
with C-2’ and C-4’, while small coupling constants with C-3’ and C-5’ (δ 115.7). The above results 
univocally indicated the relative position of each substituent on the aromatic nucleus, thus defining the 
structure of iodocionin as 2-(4-hydroxy-3-iodophenyl)-N,N,N-trimethylethanaminium. 
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Table 2. Heteronuclear coupling constant pattern for 1. 
 
 
2.2. Biological activities of compounds 1 and 2  
The capability of both compounds 1 and 2 to affect cell viability has been estimated in vitro on two 
different  cell  lines,  L5178Y  (mouse  lymphoma)  and  PC12  (rat  pheochromocytoma),  using  the 
microculture  tetrazolium  (MTT)  assay.  The  results  were  statistically  evaluated  using  the  paired 
Student’s t-test [10]. Iodocionin (1) exhibited an acute activity against lymphoma cells with an IC50 of 
7.75 μg/mL, showing 70% inhibition of cell growth at a concentration of 10 µ g/mL, while it did not 
affect at all the viability of PC12 cells. In contrast, compound 2 displayed in both cell systems no 
statistically significant reduction of cell growth at concentrations between 0.1 and 10 µ g/mL. These 
preliminary  results,  illustrated  in  Figure  2,  indicate  that  iodocionin  seems  to  selectively  inhibit 
lymphoma rather than pheochromocytoma cell proliferation. Moreover, comparison of the effects of 
compounds 1 and 2 revealed a definite structure–activity relationship for the nature of the halogen 
atom present on the aromatic ring.  
Figure 2. Effect of compounds 1 and 2 on L5178Y and PC-12 cell lines. 
 
 
 
 
 
3. Experimental Section 
3.1. General Experimental Procedures 
ESI mass spectra were obtained on an API 200 mass spectrometer. HRFABMS (glycerol matrix) 
were performed on a VG Prospec (FISONS) mass spectrometer. NMR experiments were performed on 
a Varian Unity INOVA 500 spectrometer; chemical shifts are referred to the residual solvent signal 
(CD3OD: δH = 3.31, δC = 49.0). Medium-pressure liquid chromatographies (MPLC) were carried out 
on  a  Buchi  861  apparatus  with  SiO2  (230–400  mesh)  packed  columns.  High-performance  liquid 
  C-1’  C-2’  C-3’  C-4’  C-5’  C-6’ 
H-2’  -  -  3.8 Hz  8.7 Hz  -  9.0 Hz 
H-5’  7.5 Hz  -1.0 Hz  7.5 Hz  4.4 Hz  -  - 
H-6’  -  7.4 Hz  -1.4 Hz  7.4 Hz  1.0 Hz  - Mar. Drugs 2010, 8                       
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chromatography  (HPLC)  separations  were  achieved  on  a  Waters  501  apparatus  equipped  with  an  
RI detector. 
3.2. Extraction and Isolation 
Specimens of C. edwardsii were collected at -75 m depth in the autumn of 2006 in the bay of 
Naples  (Meta  di  Sorrento,  Punta  Gradelle)  and  kept  frozen  until  used.  A  voucher  specimen  was 
deposited at the Dipartimento di Chimica delle Sostanze Naturali, Napoli, Italy. The freshly thawed 
tunicate (21.9 g dry weight after extraction) was homogenized and treated at room temperature with 
methanol  (3  ×   1  L)  and,  subsequently,  with  chloroform  (3  ×   1  L).  The  combined  extracts  were 
concentrated in vacuo to give an aqueous suspension that was subsequently extracted initially with 
EtOAc and then with BuOH. The butanol soluble material (5.4 g of a dark brown oil), obtained after 
evaporation of the solvent, was chromatographed on a RP-18 silica gel flash column using a gradient 
elution (water → methanol → chloroform).  
The fractions eluted with H2O/MeOH 1:1 were chromatographed by HPLC on an RP-18 column 
(Luna,  3  μm,  150  ×   4.60  mm),  using  MeOH/H2O  7:3  containing  TFA  0.1%  as  the  eluent  (flow  
0.5 mL/min). This separation afforded 4.5 mg of pure iodocionin (1) and 1.5 mg of compound 2, 
identified by comparison of its spectral properties with literature values.  
Iodocionin  (1). Yellow viscous oil; ESI-MS (positive ion mode): m/z = 306 [M]
+; HRFABMS 
(positive ion mode): m/z = 306.0362; the molecular formula C11H17INO
 requires 306.0349; 
1H NMR 
and 
13C NMR data (CD3OD, 500 MHz) are reported in Table 1. 
3.3. Cytotoxicity Assays 
The cytotoxicity against L5178Y (mouse lymphoma) and PC-12 (rat pheochromocytoma) cells was 
determined using the microculture tetrazolium (MTT) assay and compared to that of untreated controls 
[11–13]. Stock solutions of the test samples in EtOH 96% (v/v) were prepared. Exponentially growing 
cells  were  harvested,  counted,  and  diluted  to  the  appropriate  concentration.  50  µ L  of  the  cell 
suspension, containing 3750 cells, were pipetted into 96-well microtiter plates; subsequently, 50 µ L of 
a solution of the test samples, containing the appropriate concentration, were added to each well. A 
concentration  range  between  0.1  and  10  µ g/mL  was  chosen.  As  established  in  a  preliminary 
experiment, the low amounts of EtOH used in the assays did not affect the cells growth. The plates 
were  incubated  at  37  °C   under  5%  CO2  atmosphere  for  72  h.  Then,  a  stock  solution  of  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) was prepared (5 mg/mL 
in  phosphate-buffered  saline  (PBS;  1.5  mM  KH2PO4,  6.5  mM  Na2HPO4,  137  mM  NaCl,  
2.7 mM KCl; pH 7.4); then, 20 µ L of this solution were pipetted into each well. The yellow-colored 
MTT  penetrates  into  living  cells  and  there  undergoes  enzymatic  conversion  to  a  blue  formazan 
complex  due  to  mitochondrial  dehydrogenases.  After  an  incubation  period  of  4  h  at  37  ° C  in  a 
humidified 5% CO2 incubator, the medium was centrifuged (15 min; 20 °C ; 210 g), cells lysed with 
dimethyl sulfoxide, and the absorbance was measured at 520 nm using a scanning microtiter-well 
spectrophotometer. The color intensity is correlated with the number of healthy living cells; thus, cell 
survival was calculated using the formula:  Mar. Drugs 2010, 8                       
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survival (%) = [100 ×  (absorbance of treated cells - absorbance of culture medium)]:[(absorbance of 
untreated cells - absorbance of culture medium)].  
All experiments were carried out in ten parallel assays and repeated three times. As controls, media 
with 0.1% EGMME/DMSO were included in the experiments, as previously described [14]. 
4. Conclusions  
The number of halometabolites isolated from natural sources and structurally defined continues to 
increase,  but  most  of  the  biogenic  organohalogens  discovered  over  the  past  35  years  are  marine-
derived, biosynthesized by almost all the marine life [1]. It has been suggested that marine organisms 
might have indeed a vested interest in the biosynthesis of halogenated compounds since halogenation 
of organic molecules often confers high levels of biological activity even in precursors with little or no 
intrinsic activity [15]. Thus, the potential usefulness of these compounds for human therapy could be a 
driving force for their continuing pursuit. 
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